Browse studies

Find your next paid study

3,219 recruiting studies matching your filters

Tdcs And cogNitive traininG cOmbined for AUD (TANGO)

The overarching goal of this project is to expand the traditional expertise in non-invasive neuromodulation at the University of Minnesota towards developing n…

Alcohol Use DisorderAddiction

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MinnesotaNCT05062369

Observational

Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer (FastER)

The purpose of this study is to test whether four different supportive care programs can reduce fatigue in women with advanced or metastatic breast cancer who …

HER2-positive Breast CancerAdvanced Breast Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MiamiNCT06123988

Phase 1

A Phase 1a/b, Open-label, Dose-escalation and Dose-expansion, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of MX006 in Patients With Selected Advanced Solid Tumor Types Known to Express B7-H3

This is a Phase 1a/1b, multicenter, open-label, first-in-human (FIH) study with MX006 treatment in patients with selected tumor types known to express B7-H3. T…

Advanced and/or Metastatic Solid Tumors Known to Express B7-H3

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Myricx Pharma LimitedNCT07807241

Phase 2

A Multi-national, Open-label, Randomized Phase II/III Clinical Study of Utidelone Capsule (UTD2) Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

This is a multi-national, open-label, randomized, seamless phase II/III clinical study of UTD2 combined with fluoropyrimidine- and platinum-containing therapy …

Gastric or Gastroesophageal Junction Adenocarcinoma

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Beijing Biostar Pharmaceuticals Co., Ltd.NCT06841679

Phase 1

A Phase 1/2, Multicenter, Multi-cohort, Open-label Study of an Autologous Tumor-infiltrating Lymphocytes (TIL) Regimen With IOV-5001 in Participants With Previously Treated Advanced Solid Tumors

A Phase 1/2, multicenter, multi-cohort, open-label study of an autologous tumor-infiltrating lymphocytes (TIL) regimen with IOV-5001 in participants with previ…

Advanced Solid TumorsNon-Small Cell Lung CancerTriple Negative Breast Cancer (TNBC)+4 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Iovance Biotherapeutics, Inc.NCT07743723

Phase 3

The Effect of Erector Spinae Plane Block (ESPB) on Pediatric Pain Management Following Posterior Spinal Fusion (PSF) Surgery

This study is being done to better understand the efficacy of an erector spinae plane block (ESPB) in pain management for children with Adolescent Idiopathic S…

Adolescent Idiopathic Scoliosis (AIS)Neuromuscular ScoliosisAdolescent Idiopathic Scoliosis

Estimated

~$50 – $1,350

Actual pay is set by the research site.

University of California, San FranciscoNCT07561827

Methods of Identifying Effective Off-Guideline Treatments for Advanced Cancer Patients (CC N-of-1)

Many FDA-approved drugs are not available to patients with a particular cancer because there has been no successful clinical trial conducted for that drug agai…

Advanced Cancer

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Cancer CommonsNCT07343024

Phase 1

Dexmedetomidine Trial for Effects on Rhythms, Sleep Architecture, and Biomarker Dynamics - A Pilot Study (DEXTER)

The DEXTER study is a cross-over, double-blind, placebo-controlled pilot research study led by Dr. Peng Li. The goal of this project is to evaluate the safety,…

SleepCircadian Rhythm

Estimated

~$500 – $7,500

Actual pay is set by the research site.

Massachusetts General HospitalNCT07800910

Observational

Assessment of Adolescent and Young Adult Vaccine Confidence and Missed Opportunities for Vaccination in the Mountain West (VACCINE CONFIDENCE - WEST): A Randomized Tailored Vaccine Messaging Intervention

his study will evaluate whether tailored vaccine messaging improves vaccination-related outcomes among parents and caregivers of adolescents. Participants will…

Vaccine ConfidenceAdolescent VaccinationVaccine Uptake

Estimated

~$10 – $750

Actual pay is set by the research site.

University of UtahNCT07878442

Phase 2

An Open-Label Multi-Center Phase II Study of Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

This phase II trial studies how well atezolizumab works alone or in combination with etrumadenant or tocilizumab in treating men with localized prostate cancer…

Prostate AdenocarcinomaProstate CancerLocalized Prostate Cancer

Estimated

~$75 – $3,000

Actual pay is set by the research site.

David OhNCT03821246

Phase 1

A Phase 1, Open-label, Dose-escalation Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UGN-501 Administered Intravesically in Adult Participants With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

This study is being conducted to evaluate the safety and tolerability of UGN-501 administered intravesically in adult participants with recurrent non-muscle in…

Bladder (Urothelial, Transitional Cell) CancerNMIBCUrothelial Carcinoma Bladder+5 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.

Observational

Sacral Neuromodulation for Male Overactive Bladder

To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.

Overactive BladderUrinary Urgency IncontinenceBenign Prostatic Hyperplasia+3 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Axonics, Inc.NCT06511141